NL8200392A - Werkwijze ter bereiding van een immunogeen van pasteurella multocida. - Google Patents

Werkwijze ter bereiding van een immunogeen van pasteurella multocida. Download PDF

Info

Publication number
NL8200392A
NL8200392A NL8200392A NL8200392A NL8200392A NL 8200392 A NL8200392 A NL 8200392A NL 8200392 A NL8200392 A NL 8200392A NL 8200392 A NL8200392 A NL 8200392A NL 8200392 A NL8200392 A NL 8200392A
Authority
NL
Netherlands
Prior art keywords
strain
vaccine
pasteurella multocida
immunogen
culture
Prior art date
Application number
NL8200392A
Other languages
English (en)
Dutch (nl)
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Priority to NL8200392A priority Critical patent/NL8200392A/nl
Priority to DE8383200174T priority patent/DE3364803D1/de
Priority to EP83200174A priority patent/EP0085469B1/de
Priority to AT83200174T priority patent/ATE21033T1/de
Priority to DK42083A priority patent/DK42083A/da
Priority to JP58014681A priority patent/JPS58159423A/ja
Priority to CA000420755A priority patent/CA1193565A/en
Publication of NL8200392A publication Critical patent/NL8200392A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL8200392A 1982-02-03 1982-02-03 Werkwijze ter bereiding van een immunogeen van pasteurella multocida. NL8200392A (nl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NL8200392A NL8200392A (nl) 1982-02-03 1982-02-03 Werkwijze ter bereiding van een immunogeen van pasteurella multocida.
DE8383200174T DE3364803D1 (en) 1982-02-03 1983-02-01 Method of preparing an immunogen of pasteurella multocida
EP83200174A EP0085469B1 (de) 1982-02-03 1983-02-01 Verfahren zur Herstellung eines Immunogens aus Pasteurella Multocida
AT83200174T ATE21033T1 (de) 1982-02-03 1983-02-01 Verfahren zur herstellung eines immunogens aus pasteurella multocida.
DK42083A DK42083A (da) 1982-02-03 1983-02-02 Fremgangsmaade til fremstilling af et immunogen af pasteurella multocida
JP58014681A JPS58159423A (ja) 1982-02-03 1983-02-02 パスツレラムルトシダ菌株の培養による免疫抗原の製造方法
CA000420755A CA1193565A (en) 1982-02-03 1983-02-02 Method of preparing an immunogen of pasteurella multocida

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8200392 1982-02-03
NL8200392A NL8200392A (nl) 1982-02-03 1982-02-03 Werkwijze ter bereiding van een immunogeen van pasteurella multocida.

Publications (1)

Publication Number Publication Date
NL8200392A true NL8200392A (nl) 1983-09-01

Family

ID=19839183

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8200392A NL8200392A (nl) 1982-02-03 1982-02-03 Werkwijze ter bereiding van een immunogeen van pasteurella multocida.

Country Status (7)

Country Link
EP (1) EP0085469B1 (de)
JP (1) JPS58159423A (de)
AT (1) ATE21033T1 (de)
CA (1) CA1193565A (de)
DE (1) DE3364803D1 (de)
DK (1) DK42083A (de)
NL (1) NL8200392A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885589A (en) * 1988-04-12 1999-03-23 Intervet International B.V. Pasteurella vaccine
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
JP4734966B2 (ja) * 2005-03-03 2011-07-27 マックス株式会社 空気清浄装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1441098A (en) * 1972-03-29 1976-06-30 Wellcome Found Biological preparations

Also Published As

Publication number Publication date
JPS58159423A (ja) 1983-09-21
DE3364803D1 (en) 1986-09-04
DK42083D0 (da) 1983-02-02
ATE21033T1 (de) 1986-08-15
DK42083A (da) 1983-08-04
EP0085469B1 (de) 1986-07-30
EP0085469A1 (de) 1983-08-10
CA1193565A (en) 1985-09-17

Similar Documents

Publication Publication Date Title
Landy et al. Increased resistance to infection and accompanying alteration in properdin levels following administration of bacterial lipopolysaccharides
Maramorosch Multiplication of aster yellows virus in in vitro preparations of insect tissues
Baba Immunogenic activity of a ribosomal fraction obtained from Pasteurella multocida
NL8200392A (nl) Werkwijze ter bereiding van een immunogeen van pasteurella multocida.
US4242270A (en) Process for separating lipids from endotoxins
EP0674905B1 (de) Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
US3423505A (en) Rabies vaccine and process for preparation thereof
Ekstedt Studies on Immunity to Staphylococcal Infection in Mice: IV. The Role of Specific and Nonspecific Immunity [with Discussion]
US3548055A (en) Infectious bursal disease vaccine
EP1387693B1 (de) Saponin inaktivierte mykoplasma impfstoffe
Smith Effect of route of vaccination on the immune response of mice to a single dose of heat-killed Mycoplasma mycoides var. mycoides
US5641491A (en) Escherichia coli strain 364 and use of said strain as a vaccine
Ward et al. Factors influencing the efficacy of vaccines against vibriosis caused by Vibrio anguillarum
CN110295120A (zh) 一种罗非鱼无乳链球菌天然弱毒株及其弱毒活疫苗
Carter et al. Assessment of typhoid vaccines by using the intraperitoneal route of challenge
Springer et al. Protection of mice against lethal Staphylococcus infection by Escherichia coli O86 fractions
US3843451A (en) Microorganism production
CN103520717B (zh) 丙氨酸作为疫苗佐剂的应用
Cameron The significance of the endotoxin and pyogenic factor of Corynebacterium pseudotuberculosis in immunity
KR100787830B1 (ko) 돈단독균 불활화항원에 돈단독균 특이정제단백 항원을 첨가한 돈단독균 불활화백신의 제조방법
CN106085968A (zh) 一种水貂伪狂犬灭活疫苗及其制备方法和用途
Chute et al. Bacterins and drugs for the control of experimental fowl cholera
Hasenclever et al. Attempts to immunize mice against sporotrichosis
EP1204420B1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe
Olitzki et al. Comparative studies on Salmonella typhi grown in vivo and in vitro III. The immunizing potencies of acetone-killed vaccines prepared from in vivo and in vitro grown bacteria and the immunizing potency of substances isolated from infected organs

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed